Total Credits: 1.25 including 1.25 AOA Category 1-A Credit(s)
This session will provide an overview of the current COVID-19 pandemic.
Upon completion of this presentation, participants will be able to:
Statement of Accreditation
The Texas Osteopathic Medical Association (TOMA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. TOMA designates this program for a maximum of 1.25 AOA Category 1-A credits and will report CME credits commensurate with the extent of the physician’s participation in this activity.
Grievance Policy
All grievances may be directed to TOMA's Executive Director at toma@txosteo.org. All grievances will receive an initial response within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
| Covid - Where We're going (53.39 MB) | 67 Pages | Available after Purchase |
Dr. Midturi completed his medical training at University of North Texas Health Science Center/Texas College of Osteopathic Medicine, Fort Worth. He then pursued combined training in Internal Medicine-Pediatrics, followed by an Adult Infectious Disease fellowship, all at Scott & White Healthcare. He obtained a master’s in public health degree during his fellowship through Texas A&M University, School of Rural Public Health. His interest in international healthcare and HIV led to work through Baylor College of Medicine (Baylor International Pediatrics AIDS Initiative) in Malawi, Africa, 2006-2008. He returned to Baylor Scott & White Health in 2008. He currently serves as the Director of Infectious Disease Division since 2013. He has conducted research in HIV, influenza, Clostridium difficile colitis, and antifungal agents. He is interested in preventative aspects of infectious disease and population health. He enjoys teaching, time with this family, and travel.
Dr. Midturi discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|